BioNexus Gene Lab Corp Common stock (BGLC) went public on September 16, 2020, when it opened at a split-adjusted price of $0.004.
| DATE | OPEN | HIGH | LOW | CLOSE | VOLUME |
|---|---|---|---|---|---|
April 2025 | $2.2600 | $3.4900 | $2.0070 | $2.8700 | 35,050,394 |
March 2025 | $3.1400 | $4.0500 | $2.2700 | $2.3600 | 2,908,500 |
February 2025 | $4.1500 | $4.1900 | $3.1000 | $3.2800 | 159,870 |
January 2025 | $2.9900 | $8.4000 | $2.8000 | $4.0800 | 21,431,760 |
December 2024 | $2.3300 | $5.1000 | $2.1100 | $2.8000 | 3,577,950 |
November 2024 | $3.6100 | $3.7900 | $2.3100 | $2.3100 | 191,110 |
October 2024 | $4.6000 | $4.6000 | $3.5100 | $3.6000 | 146,950 |
September 2024 | $4.6000 | $5.8000 | $3.4000 | $4.4500 | 2,010,330 |
August 2024 | $4.8000 | $5.1700 | $4.0300 | $4.4100 | 248,480 |
July 2024 | $4.7500 | $6.5000 | $4.5500 | $4.8800 | 252,690 |
June 2024 | $4.4600 | $7.5000 | $4.3100 | $4.7500 | 637,170 |
May 2024 | $6.2500 | $6.3000 | $4.2000 | $4.2500 | 148,130 |
April 2024 | $6.9200 | $10.0000 | $5.8000 | $6.2000 | 592,960 |
March 2024 | $6.1000 | $12.0000 | $6.0000 | $7.0600 | 593,810 |
February 2024 | $4.7000 | $33.9000 | $4.0000 | $5.6900 | 8,601,320 |
January 2024 | $5.5800 | $6.0000 | $4.1100 | $4.6900 | 105,010 |
December 2023 | $8.4500 | $9.5000 | $4.7000 | $5.3000 | 548,290 |
November 2023 | $3.9800 | $16.0000 | $3.1000 | $9.5000 | 12,142,310 |
October 2023 | $8.1900 | $8.2600 | $3.8400 | $4.1900 | 323,640 |
September 2023 | $16.5000 | $17.0000 | $7.7000 | $8.7000 | 924,490 |
August 2023 | $21.6000 | $24.9700 | $6.5100 | $17.1000 | 12,825,270 |
July 2023 | $41.8800 | $178.8000 | $18.0000 | $22.3000 | 4,023,877 |
June 2023 | $25.2000 | $70.5600 | $9.6000 | $26.5200 | 2,831 |
May 2023 | $27.7200 | $72.0000 | $24.0000 | $34.5600 | 2,667 |
April 2023 | $64.8000 | $67.2000 | $27.7200 | $39.4800 | 199 |
